Helicobacter pylori infection and idiopathic thrombocytopenic purpura

International Journal of Hematology

Volumn 81, Issue 2, 2005, Pages 113-118

  Fujimura, Kingo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Eradication; Helicobacter pylori infection; ITP; Molecular mimicry

Indexed keywords

AMOXICILLIN; ANTIBODY; CLARITHROMYCIN; LANSOPRAZOLE; VON WILLEBRAND FACTOR;

BLEEDING; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MOLECULAR MIMICRY; PREVALENCE; REVIEW; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

BLOOD PLATELETS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 13944261132     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04161     Document Type: Review

References (37)

1. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349:1531-1536.
2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995-1008.
3. Kuwana M, Kaburaki J, Kitasato H, et al. Immunodominant epitopeson glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood. 2001;98:130-139.
4. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacler pylon. Lancet. 1998;352:878.
5. Suerbaum S, Michetti P. Helicobacler pylori infection. N Engl J Med. 2002:347:1175-1186.
6. Gasbarrini A, Carloni E, Gasbarrini G, Menard A. Helicobacter pylori and extra gastric diseases-other helicobacters. Helicobacter. 2003;8:68-76.
7. De Luis DA, Varela C, de la Calle H, et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998;26:259-263.
8. Figura N, Giordano N, Burroni D, et al. Sjogrens syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1994;6:321-322.
9. Zentilin P, Savarino V, Gamero A, Accardo S, Serino B. Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? Gastroenterology. 1999;116:503-504.
10. Emillia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood. 2001;97:812-814.
11. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Brit J Haematol. 2002;118:584-588.
12. Hashino S, Mori A, Suzuki S, et al. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol. 2003;77:188-191.
13. Ando K, Shimamoto T, Tauchi T, et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol. 2003;77:239-244.
14. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-766.
15. Rajantie J, Klemola T. Helicobacter pylori and idiopathic thrombocytopenic purpura in children. Blood. 2003;101:1660.
16. Jaing TH, Yang CP, Hung IJ, Chiu CH, Chang KW. Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura. Acta Paediatr. 2003;92:1153-1157.
17. Michel M, Cooper N, Christelle J, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood. 2004;103:890-896.
18. Ando T, Tsuzuki T, Mizuno T, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter. 2004;9:443-52.
19. Emilia G, Luppi M, Morselli M, Potenza L, Apollo ND, Torelli G. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Brit J Haematol. 2002;118:1198-1199.
20. Jarque I, Andreu R, Llopis I, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Brit J Haematol. 2001;115:1002-1003.
21. Michel M, Khellaf M, Desforges L, et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med. 2004;162:1033-1035.
22. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori Cag A protein may be involved in the pathogenesis of pylori-associated chronic idiopathic thrombocytopenic purpura. Brit J Haematol. 2004;124:91-96.
23. Sato R, Murakami K, Watanabe K, et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med. 2004;164:1904-1907.
24. Kurtoglu E, Kayacetin E, Ulger A. Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura. World J Gastroenterol. 2004;10:2113-2115.
25. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162-168.
26. Segal BM, Klinman DM, Shevach EM. Microbial products induce autoimmune disease by an IL-12 dependent pathway. J Immunol. 1997;158:5087-5090.
27. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nature Med. 2001;7:899-905.
28. Yuceyar H, Saruc M, Kokuludag A, Terzioglu E, Goksel G, Isisag A. The systemic cellular immune response in the Helicobacter pylori-associated duodenal ulcer and chronic antral gastritis. Hepatogastroenterology. 2002;49:1177-1179.
29. Pellicano R, Touscoz GA, Smedile A, et al. Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection. Dig Dis Sci. 2004;49:395-398.
30. Amedei A, Bergman MP, Appelmelk BJ, et al. Molecular mimicry between Helicobacter pylori antigens and H+,K+ -adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003;198:1147-1156.
31. Rad R, Gerhard M, Lang R, et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol. 2002;168:3033-3041.
32. McCrae KR. Helicobacter pylori and ITP: many questions, few answers. Blood. 2004;103:751-752.
33. Takahashi T, Yujiri T,Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to difference in the bacterial strains. Blood. 2004;104:594.
34. Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846-1854.
35. Veneri D, Gottardi M, Guizzardi E, Zanuso C, Krampera M, Franchini M. Idiopathic thrombocytopenic purpura, Helicobacter pylori infection, and HLA class II alleles. Blood. 2002;100:1925-1926.
36. Magnusson PKE, Enroth H, Eriksson I, et al. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res. 2001;61:2684-2689.
37. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter. 2004;9:342-346.